The ABC of clinical and experimental adjuvants—A brief overview
Abstract Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only alu...
Gespeichert in:
| Veröffentlicht in: | Immunology letters 2010-01, Vol.128 (1), p.29-35 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 35 |
|---|---|
| container_issue | 1 |
| container_start_page | 29 |
| container_title | Immunology letters |
| container_volume | 128 |
| creator | Brunner, Richard Jensen-Jarolim, Erika Pali-Schöll, Isabella |
| description | Abstract Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings. |
| doi_str_mv | 10.1016/j.imlet.2009.10.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2999744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165247809002491</els_id><sourcerecordid>744692614</sourcerecordid><originalsourceid>FETCH-LOGICAL-c611t-b2c00dbd35f087f4263bb48e9dcc302dadd8d07081b3cff660bad65bc918e9873</originalsourceid><addsrcrecordid>eNqFkcmO1DAQhi0EYpqBJ0BCuXFKU7az2AdGalps0kgcGM6WlwrjkI4bO2mYGw_BE_IkOHSzXjhZKn-16PsJeUhhTYE2T_q13w04rRmAzJU1QH2LrKhoZQl1xW6TVabqklWtOCP3UuoBaM0rfpecUSlkLap2RTZX11hsnm2L0BV28KO3eij06Ar8vMfodzhOS8H180GPU_r25eumMNFjV4QDxoPHT_fJnU4PCR-c3nPy7sXzq-2r8vLNy9fbzWVpG0qn0jAL4IzjdQei7SrWcGMqgdJZy4E57Zxw0IKghtuuaxow2jW1sZJmSLT8nFwc5-5ns0Nn82VRD2qfj9TxRgXt1d8_o79W78NBMSllW1V5wOPTgBg-zpgmtfPJ4jDoEcOcVGYayRq6kPxI2hhSitj92kJBLe5Vr364V4v7pZjd565Hfx74u-ckOwNPjwBmTVldVMl6HC06H9FOygX_nwUX__T_TOwD3mDqwxzHnICiKjEF6u0S_5I-SABWScq_A5AJrWs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>744692614</pqid></control><display><type>article</type><title>The ABC of clinical and experimental adjuvants—A brief overview</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Brunner, Richard ; Jensen-Jarolim, Erika ; Pali-Schöll, Isabella</creator><creatorcontrib>Brunner, Richard ; Jensen-Jarolim, Erika ; Pali-Schöll, Isabella</creatorcontrib><description>Abstract Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>DOI: 10.1016/j.imlet.2009.10.005</identifier><identifier>PMID: 19895847</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvant ; Adjuvants, Immunologic - pharmacology ; Adjuvants, Immunologic - therapeutic use ; Allergy and Immunology ; Aluminum ; Aluminum Compounds - immunology ; Aluminum Compounds - therapeutic use ; Animals ; Bacterial Toxins - immunology ; Cholera toxin B ; Flagellin ; Flagellin - immunology ; Freund's Adjuvant - immunology ; Freund’s adjuvant ; Humans ; Immune response ; Lipid A - analogs & derivatives ; Lipid A - immunology ; MF59 ; Monophosphoryl lipid A ; Nanoparticles ; Poly-lactid-co-glycolid acid ; Polysorbates ; Squalene - immunology ; Vaccines ; Virosomes ; Virosomes - immunology</subject><ispartof>Immunology letters, 2010-01, Vol.128 (1), p.29-35</ispartof><rights>Elsevier B.V.</rights><rights>2009 Elsevier B.V.</rights><rights>2009 Elsevier B.V. All rights reserved. 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c611t-b2c00dbd35f087f4263bb48e9dcc302dadd8d07081b3cff660bad65bc918e9873</citedby><cites>FETCH-LOGICAL-c611t-b2c00dbd35f087f4263bb48e9dcc302dadd8d07081b3cff660bad65bc918e9873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165247809002491$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19895847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brunner, Richard</creatorcontrib><creatorcontrib>Jensen-Jarolim, Erika</creatorcontrib><creatorcontrib>Pali-Schöll, Isabella</creatorcontrib><title>The ABC of clinical and experimental adjuvants—A brief overview</title><title>Immunology letters</title><addtitle>Immunol Lett</addtitle><description>Abstract Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings.</description><subject>Adjuvant</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Allergy and Immunology</subject><subject>Aluminum</subject><subject>Aluminum Compounds - immunology</subject><subject>Aluminum Compounds - therapeutic use</subject><subject>Animals</subject><subject>Bacterial Toxins - immunology</subject><subject>Cholera toxin B</subject><subject>Flagellin</subject><subject>Flagellin - immunology</subject><subject>Freund's Adjuvant - immunology</subject><subject>Freund’s adjuvant</subject><subject>Humans</subject><subject>Immune response</subject><subject>Lipid A - analogs & derivatives</subject><subject>Lipid A - immunology</subject><subject>MF59</subject><subject>Monophosphoryl lipid A</subject><subject>Nanoparticles</subject><subject>Poly-lactid-co-glycolid acid</subject><subject>Polysorbates</subject><subject>Squalene - immunology</subject><subject>Vaccines</subject><subject>Virosomes</subject><subject>Virosomes - immunology</subject><issn>0165-2478</issn><issn>1879-0542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcmO1DAQhi0EYpqBJ0BCuXFKU7az2AdGalps0kgcGM6WlwrjkI4bO2mYGw_BE_IkOHSzXjhZKn-16PsJeUhhTYE2T_q13w04rRmAzJU1QH2LrKhoZQl1xW6TVabqklWtOCP3UuoBaM0rfpecUSlkLap2RTZX11hsnm2L0BV28KO3eij06Ar8vMfodzhOS8H180GPU_r25eumMNFjV4QDxoPHT_fJnU4PCR-c3nPy7sXzq-2r8vLNy9fbzWVpG0qn0jAL4IzjdQei7SrWcGMqgdJZy4E57Zxw0IKghtuuaxow2jW1sZJmSLT8nFwc5-5ns0Nn82VRD2qfj9TxRgXt1d8_o79W78NBMSllW1V5wOPTgBg-zpgmtfPJ4jDoEcOcVGYayRq6kPxI2hhSitj92kJBLe5Vr364V4v7pZjd565Hfx74u-ckOwNPjwBmTVldVMl6HC06H9FOygX_nwUX__T_TOwD3mDqwxzHnICiKjEF6u0S_5I-SABWScq_A5AJrWs</recordid><startdate>20100118</startdate><enddate>20100118</enddate><creator>Brunner, Richard</creator><creator>Jensen-Jarolim, Erika</creator><creator>Pali-Schöll, Isabella</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20100118</creationdate><title>The ABC of clinical and experimental adjuvants—A brief overview</title><author>Brunner, Richard ; Jensen-Jarolim, Erika ; Pali-Schöll, Isabella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c611t-b2c00dbd35f087f4263bb48e9dcc302dadd8d07081b3cff660bad65bc918e9873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adjuvant</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Allergy and Immunology</topic><topic>Aluminum</topic><topic>Aluminum Compounds - immunology</topic><topic>Aluminum Compounds - therapeutic use</topic><topic>Animals</topic><topic>Bacterial Toxins - immunology</topic><topic>Cholera toxin B</topic><topic>Flagellin</topic><topic>Flagellin - immunology</topic><topic>Freund's Adjuvant - immunology</topic><topic>Freund’s adjuvant</topic><topic>Humans</topic><topic>Immune response</topic><topic>Lipid A - analogs & derivatives</topic><topic>Lipid A - immunology</topic><topic>MF59</topic><topic>Monophosphoryl lipid A</topic><topic>Nanoparticles</topic><topic>Poly-lactid-co-glycolid acid</topic><topic>Polysorbates</topic><topic>Squalene - immunology</topic><topic>Vaccines</topic><topic>Virosomes</topic><topic>Virosomes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brunner, Richard</creatorcontrib><creatorcontrib>Jensen-Jarolim, Erika</creatorcontrib><creatorcontrib>Pali-Schöll, Isabella</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brunner, Richard</au><au>Jensen-Jarolim, Erika</au><au>Pali-Schöll, Isabella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The ABC of clinical and experimental adjuvants—A brief overview</atitle><jtitle>Immunology letters</jtitle><addtitle>Immunol Lett</addtitle><date>2010-01-18</date><risdate>2010</risdate><volume>128</volume><issue>1</issue><spage>29</spage><epage>35</epage><pages>29-35</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><abstract>Abstract Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>19895847</pmid><doi>10.1016/j.imlet.2009.10.005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0165-2478 |
| ispartof | Immunology letters, 2010-01, Vol.128 (1), p.29-35 |
| issn | 0165-2478 1879-0542 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2999744 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adjuvant Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Allergy and Immunology Aluminum Aluminum Compounds - immunology Aluminum Compounds - therapeutic use Animals Bacterial Toxins - immunology Cholera toxin B Flagellin Flagellin - immunology Freund's Adjuvant - immunology Freund’s adjuvant Humans Immune response Lipid A - analogs & derivatives Lipid A - immunology MF59 Monophosphoryl lipid A Nanoparticles Poly-lactid-co-glycolid acid Polysorbates Squalene - immunology Vaccines Virosomes Virosomes - immunology |
| title | The ABC of clinical and experimental adjuvants—A brief overview |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20ABC%20of%20clinical%20and%20experimental%20adjuvants%E2%80%94A%20brief%20overview&rft.jtitle=Immunology%20letters&rft.au=Brunner,%20Richard&rft.date=2010-01-18&rft.volume=128&rft.issue=1&rft.spage=29&rft.epage=35&rft.pages=29-35&rft.issn=0165-2478&rft.eissn=1879-0542&rft_id=info:doi/10.1016/j.imlet.2009.10.005&rft_dat=%3Cproquest_pubme%3E744692614%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=744692614&rft_id=info:pmid/19895847&rft_els_id=S0165247809002491&rfr_iscdi=true |